Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody-drug conjugates
Biotech
NextCure stops programs to take ADC fight to Big Pharma trio
NextCure is seeking partners for its existing clinical candidate and other preclinical programs to free up cash for its new priority.
Nick Paul Taylor
Nov 8, 2024 6:16am
ADC Therapeutics axes lead solid tumor drug after phase 1 blow
Nov 7, 2024 8:24am
MacroGenics pauses work on ADC pending mature survival data
Nov 6, 2024 4:44am
Ono inks $700M biobuck deal to bag preclinical LigaChem ADC
Oct 10, 2024 9:40am
AstraZeneca, Daiichi ADC fails to improve breast cancer survival
Sep 23, 2024 7:23am
Merck, Daiichi ADC hits goal in phase 3 lung cancer study
Sep 17, 2024 7:13am
